SHEIN Collaborates with Carly Lawrence for a Glamorous and Cozy FW24 Collection
SHEIN Collaborates with Carly Lawrence for a Glamorous and Cozy FW24 Collection
05 sept. 2024 08h30 HE | SHEIN
Toronto, Sept. 05, 2024 (GLOBE NEWSWIRE) -- SHEIN, the leading global fashion e-retailer, is thrilled to announce their collaboration with Carly Lawrence, the alumna from Netflix’s "Too Hot to...
BioCardia-Final-Logo-2016-JPEG.jpg
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction
08 juil. 2024 07h00 HE | BioCardia, Inc.
CellProthera, and BioCardia [Nasdaq: BCDA], today announce success from a collaborative Phase II trial of ProtheraCytes for the treatment of AMI.
Centogene_Logo.png
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
20 juin 2024 08h00 HE | Centogene NV
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug...
NBME collaborates wi
NBME collaborates with medical schools to advance workplace-based assessment in medical education
11 juin 2024 10h42 HE | NBME
PHILADELPHIA, June 11, 2024 (GLOBE NEWSWIRE) -- NBME is collaborating with five medical schools to explore the creation of a data-driven insights model to advance workplace-based assessment and data...
Centogene_Logo.png
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
14 mai 2024 08h30 HE | Centogene NV
CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued...
NBME Appoints New Vice President of Competency-Based Assessment
NBME Appoints New Vice President of Competency-Based Assessment
16 avr. 2024 10h55 HE | NBME
PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- NBME, a leading medical assessment company, has recently appointed Christopher Feddock, MD, to Vice President of Competency-Based Assessment (CBA) in...
Centogene_Logo.png
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
19 mars 2024 06h30 HE | Centogene NV
Longstanding global partnership provides an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 19, 2024 ...
Centogene_Logo.png
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
25 janv. 2024 06h30 HE | Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare...
Latin America Grants Program
NBME Revitalizes Grants Program to Enhance Assessment in Latin America
18 janv. 2024 13h46 HE | NBME
PHILADELPHIA, Jan. 18, 2024 (GLOBE NEWSWIRE) -- NBME renews the Latin America Grants Program to continue its commitment to advancing innovative approaches to medical education and enriching the...
Centogene_Logo.png
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment
27 juin 2023 07h30 HE | Centogene NV
Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) based in RiyadhJV...